First report on ototoxicity of meglumine antimoniate.
Rev Inst Med Trop Sao Paulo
; 56(5): 439-42, 2014.
Article
em En
| MEDLINE
| ID: mdl-25229226
INTRODUCTION: Pentavalent antimonials are the first drug of choice in the treatment of tegumentary leishmaniasis. Data on ototoxicity related with such drugs is scarcely available in literature, leading us to develop a study on cochleovestibular functions. CASE REPORT: A case of a tegumentary leishmaniasis patient, a 78-year-old man who presented a substantial increase in auditory threshold with tinnitus and severe rotatory dizziness during the treatment with meglumine antimoniate, is reported. These symptoms worsened in two weeks after treatment was interrupted. CONCLUSION: Dizziness and tinnitus had already been related to meglumine antimoniate. However, this is the first well documented case of cochlear-vestibular toxicity related to meglumine antimoniate.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Compostos Organometálicos
/
Limiar Auditivo
/
Zumbido
/
Tontura
/
Meglumina
/
Antiprotozoários
Limite:
Aged
/
Humans
/
Male
Idioma:
En
Revista:
Rev Inst Med Trop Sao Paulo
Ano de publicação:
2014
Tipo de documento:
Article
País de afiliação:
Brasil
País de publicação:
Brasil